The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies
Open accessAbstract
Objective: To quantify the risk of developing dementia in those with mild cognitive impairment (MCI). Method: Meta‐analysis of inception cohort studies. Results: Forty‐one robust cohort studies were identified. To avoid heterogeneity clinical studies, population studies and clinical trials were analysed separately. Using Mayo defined MCI at baseline and adjusting for sample size, the cumulative proportion who progressed to dementia, to Alzheimer’s disease (AD) and to vascular dementia (VaD) was 39.2%, 33.6% and 6.2%, respectively in specialist settings and 21.9%, 28.9% and 5.2%, respectively in population studies. The adjusted annual conversion rate (ACR) from Mayo defined MCI to dementia, AD and VaD was 9.6%, 8.1% and 1.9%, respectively in specialist clinical settings and 4.9%, 6.8% and 1.6% in community studies. Figures from non‐Mayo defined MCI and clinical trials are also reported. Conclusion: The ACR is approximately 5–10% and most people with MCI will not progress to dementia even after 10 years of follow‐up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals diagnosed with MCI are a heterogeneous group, with only about 30 % of them developing Alzheimer’s dementia within 3 years after clinical MCI diagnosis [8].”
From Psychotherapeutic interventions in individuals at risk for Alzheimer’s dementia: a systematic review (2022) · cites this paper as [8]
Citations
Cites
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Petersen, R. C. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000313 · Cited by 1,082
Natural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037
Aging, Memory, and Mild Cognitive Impairment
Petersen, R. C., Kokmen, E., Waring, S. C., Smith, G. E., Ivnik, R. J., & Tangelos, E. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004717 · Cited by 895
Mild cognitive impairment in the elderly: Predictors of dementia
Flicker, C., Ferris, S. H., & Reisberg, B. (1991) · Neurology · doi:10.1212/wnl.41.7.1006 · Cited by 838
Research works printed but not linked: 1
- Breitner JCS, 2008, Onset of Alzheimer’s dementia occurs commonly without prior cognitive impairment, T130
Cited by
Sorted by citations
Items 701–800 of 1,000
Association between whole blood essential trace elements and cognitive function in older adults
Lin, Y., Meng, L., Guo, F., Zhang, X., Yang, D., Yao, X., Jin, M., Wang, J., Tang, M., & Chen, K. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115114 · Cited by 16
Stankeviciute, L. S., Blackman, J., Tort‐Colet, N., Fernández‐Arcos, A., Sánchez‐Benavides, G., Suárez‐Calvet, M., Iranzo, Á., Molinuevo, J. L., Gispert, J. D., Coulthard, E. J., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14108 · Cited by 17
Nallapu, B. T., Initiative, T. A. D. N., Petersen, K. K., Lipton, R. B., Davatzikos, C. A., & Ezzati, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230620 · Cited by 17
Hamilton, C. A., Donaghy, P. C., Durcan, R., Ciafone, J., Olsen, K., Roberts, G., Firbank, M., Allan, L. M., Taylor, J., O'Brien, J. T., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209499 · Cited by 17
“29 Progression rates in this study approximate or exceed the crude annualized progression estimates reported in previous studies without comprehensive phenotyping 30 bio-marker risk strati fi cation.”
ResultFrom Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion
Menegon, F., Marchi, F. D., Aprile, D., Zanelli, I., Decaroli, G., Comi, C., & Tondo, G. (2024) · Biomedicines · doi:10.3390/biomedicines12081675 · Cited by 18
Nesset, M., Kersten, H., & Ulstein, I. D. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000363734 · Cited by 19
Ma, D. Y., Wong, C., Leung, G. T. Y., Fung, A. W. T., Chan, W. C., & LAM, L. C. W. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.10.003 · Cited by 17
Khoury, R., & Grossberg, G. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0590-9 · Cited by 16
Vonk, J. M. J., Greving, J. P., Gudnason, V. G., Launer, L. J., & Geerlings, M. I. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00785-x · Cited by 19
Sakakibara, R., HAMANO, H., & Hiromitsu, Y. A. G. I. (2014) · LUTS Lower Urinary Tract Symptoms · doi:10.1111/luts.12068 · Cited by 17
Pike, K. E., Kinsella, G., Ong, B., Mullaly, E., Rand, E. H., Storey, E., Ames, D. J., Saling, M. M., Clare, L., & Parsons, S. (2013) · The Clinical Neuropsychologist · doi:10.1080/13854046.2013.809149 · Cited by 20
“The condition known as amnestic mild cognitive impairment (aMCI) carries an increased risk of developing AD (Mitchell & Shiri-Feshki, 2009; Petersen et al., 2009) and has received much attention as a possible precursor to AD.”
BackgroundImpact of Patient Mild Cognitive Impairment on Physician Decision-Making for Treatment
Blair, E. M., Zahuranec, D. B., Langa, K. M., Forman, J. H., Reale, B. K., Kollman, C. D., Giordani, B., & Levine, D. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200700 · Cited by 18
Cognitive stimulation in elderly people
Apóstolo, J., Rosa, A., Castro, I., & Cardoso, D. (2013) · Revista Portuguesa de Enfermagem de Saúde Mental · doi:10.19131/rpesm.0050 · Cited by 16
Performance of Validated MicroRNA Biomarkers for Alzheimer’s Disease in Mild Cognitive Impairment
Sandau, U. S., Wiedrick, J. T., Smith, S. J., McFarland, T. J., Lusardi, T. A., Lind, B., Harrington, C. A., Lapidus, J., Galasko, D. R., Quinn, J. F., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200396 · Cited by 16
Eliassen, I. V., Fladby, T., Kirsebom, B., Waterloo, K. K., Eckerström, M., Wallin, A., Bråthen, G., Aarsland, D., & Hessen, E. (2020) · Neuropsychology · doi:10.1037/neu0000698 · Cited by 16
Chen, N., Cao, J., Zhang, W., Chen, Y., & Xu, L. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-065125 · Cited by 16
Dinesh, D., Shao, Q., Palnati, M., McDannold, S. E., Zhang, Q., Monfared, A. A. T., Jasuja, G. K., Davila, H. W., Xia, W., Moo, L. R., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13071 · Cited by 17
Wang, W., Zhang, S., Wang, Z., Luo, X., Luan, P., Hramov, A. E., Kurths, J., He, C., & Li, J. (2023) · IEEE Transactions on Cognitive and Developmental Systems · doi:10.1109/tcds.2023.3283406 · Cited by 16
“According to the results of multiple examined studies, 38% of respondents with mild cognitive impairment (MCI) who were tracked for five years or longer suffered from dementia [5].”
ResultHandgrip strength, physical activity and incident mild cognitive impairment and dementia
Werneck, A. O., Araújo, R. H. D. O., da Silva, D. R. P., & Vancampfort, D. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.107789 · Cited by 18
Yamashita, S., Kawada, N., Wang, W., Susaki, K., Takeda, Y., Kimura, M., Iwama, Y., Miura, Y., Sugano, M., & Matsuoka, R. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01844-w · Cited by 16
Owens, C. D., Pinto, C. B., Mukli, P., Szarvas, Z., Péterfi, A., Detwiler, S., Olay, L., Olson, A. L., Li, G., Galván, V., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289508 · Cited by 16
Warren, A. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1293284 · Cited by 21
Maimaitituerxun, R., Chen, W., Xiang, J., Xie, Y., Xiao, F., Wu, X. Y., Chen, L., Yang, J., Liu, A., & Dai, W. (2024) · Brain and Behavior · doi:10.1002/brb3.3456 · Cited by 15
“Accumulated evidence has consistently shown that the presence of MCI in the general population was associated with increased risk of dementia (Davis et al., 2018; Mitchell & Shiri-Feshki, 2009; Zhang et al., 2021).”
BackgroundDeng, J., Wang, H., Fu, T., Xu, C., Zhu, Q., Guo, L., & Zhu, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1365589 · Cited by 17
NHG-Standaard Dementie (derde herziening)+
van Charante, E. P. M., Perry, M., Vernooij-Dassen, M. J. F. J., Boswijk, D., Stoffels, J., Achthoven, L., & Luning-Koster, M. N. (2012) · Cited by 16
Cancer-related cognitive impairment in older adults
Edelstein, A., Pergolizzi, D., & Alici, Y. (2017) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000254 · Cited by 15
“7% of individuals who meet criteria for MCI will progress to dementia annually, challenging the presupposed concept that MCI is an intermediate state that inevitably converts to dementia [7].”
BackgroundFang, J., Cui, L., Sun, Y. J., Feng, L., & Ong, C. N. (2017) · Metabolomics · doi:10.1007/s11306-017-1249-0 · Cited by 16
Fausto, B. A., Badana, A. N. S., Arnold, M. L., Lister, J. J., & Edwards, J. D. (2018) · Journal of Speech Language and Hearing Research · doi:10.1044/2017_jslhr-h-17-0263 · Cited by 16
Animal Research for Alzheimer Disease: Failures of Science and Ethics
Pippin, J. J., Cavanaugh, S. E., & Pistollato, F. (2019) · BRILL eBooks · doi:10.1163/9789004391192_021 · Cited by 16
“Vascular and mixed dementia overlap considerably with AD; nearly all cases of vascular dementia display characteristics of AD (Thal, Grin berg and Attems, 2012 ), and prevalence figures do not include the AD precur sor, mild cognitive impairment (Mc I), making the percentage of dementia and incipient dementia attrib…”
Ó’Caoimh, R., & Molloy, D. W. (2019) · Diagnostics · doi:10.3390/diagnostics9030093 · Cited by 16
“The MMSE has a “floor” effect such that a score of zero does not always support dementia and a “low ceiling” effect such that a normal score does not always mean normal cognition [11].”
BackgroundIshihara, K., Izawa, K. P., Kitamura, M., Shimogai, T., Kanejima, Y., Morisawa, T., & Shimizu, I. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.12.009 · Cited by 16
Arruda, J. E., McInnis, M. C., & Steele, J. (2020) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2020.05.012 · Cited by 16
Liu, H., Initiative, A. D. N., Lutz, M. W., & Luo, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210700 · Cited by 17
“About one-third of MCI patients will develop AD over time [17, 18].”
Villeneuve, S., & Belleville, S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.004 · Cited by 18
Religious affiliation and the risk of dementia in Taiwanese elderly
Lin, K., Chou, Y., Chen, J., Chen, C.-D., Yang, S.-Y., Chen, T., Sun, Y., Wen, L., Yip, P., Chu, Y., et al. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.01.009 · Cited by 16
der Linden, M. V., & der Linden, A. J. V. (2016) · Dementia · doi:10.1177/1471301216657270 · Cited by 20
ALBA Screening Instrument (ASI): A brief screening tool for Lewy Body Dementia
Basalo, M. M. G., Fernández, M. C., Quintana, M. O., Rojas, J. I., Básalo, M. J. G., Bogliotti, E., Cámpora, N., Fernandez, M., Berríos, W., Cristiano, E., et al. (2017) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2017.01.001 · Cited by 17
Persson, K., Barca, M. L., Eldholm, R. S., Cavallin, L., Benth, J. Š., Selbæk, G., Brækhus, A., Saltvedt, I. T., & Engedal, K. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477342 · Cited by 17
Quaranta, D., Gainotti, G., Giuda, D. D., Vita, M. G., Cocciolillo, F., Lacidogna, G., Guglielmi, V., Masullo, C., Giordano, A., & Marra, C. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.10.008 · Cited by 17
“…investigations, it became clear that only some MCI patients progress to dementia, whereas most of them do not convert to AD or another form of dementia, but remain stable or even revert to a normal stage (Dickerson et al., 2007; Koepsell and Monsell, 2012; Mitchell and Shiri-Feshki, 2009).”
BackgroundZeng, J., Hu, K., Wang, Z., Huang, Y.-C., Zhang, Y., Peng, H., & Ma, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00086 · Cited by 18
Lim, B., Grøntvedt, G. R., Bathala, P., Kale, S., Campbell, C. T., Stengelin, M. K., Sando, S. B., Prassas, I., Diamandis, E. P., & Bråthen, G. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.013 · Cited by 15
Liu, S., Cao, Y., Liu, J., Ding, X., Coyle, D., & Initiative, A. D. N. (2022) · International Journal of Machine Learning and Cybernetics · doi:10.1007/s13042-022-01570-2 · Cited by 16
“Studies have shown a 3–15% conversion rate of MCI to AD (progressive MCI, pMCI) every year [22, 52].”
BackgroundMild cognitive impairment in multiple system atrophy: a brain network disorder
Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02682-x · Cited by 15
“In PD, the conversion rate to dementia ranges between 25 and 69% (Janvin et al. 2006; Mitchell and Shiri-Feshki 2009; Nicoletti et al. 2019) and in DLB around 50% (Fujishiro et al.”
BackgroundKim, H. H., Hillis, A. E., & Themistocleous, C. K. (2024) · Brain Sciences · doi:10.3390/brainsci14070652 · Cited by 15
“Although a higher risk of developing dementia characterizes individuals with MCI, not all individuals with MCI will progress to dementia; some may remain stable, and others even regress to a condition of healthy aging [10–12].”
BackgroundEkman, U., Ferreira, D., Muehlboeck, J., Wallert, J., Rennie, A., Eriksdotter, M., Wahlund, L., & Westman, E. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-1478-3 · Cited by 15
Treatment of Dementia With Bosutinib
Mahdavi, K. D., Jordan, S. E., Barrows, H. R., Pravdic, M., Habelhah, B., Evans, N. E., Blades, R. B., Iovine, J., Becerra, S. A., Steiner, R. A., et al. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000918 · Cited by 15
Bao, Y., Chau, A. C. M., Chiu, P. K., Shea, Y. F., Kwan, J. S. K., Chan, F. H. W., & Mak, H. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200890 · Cited by 15
Maruta, M., Makizako, H., Ikeda, Y., Miyata, H., Nakamura, A., Han, G., Shimokihara, S., Tokuda, K., Kubozono, T., Ohishi, M., et al. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5544 · Cited by 17
“Older adults with MCI are approximately three times more likely to develop AD than those without,(8) and the annual conversion rate is approximately 5%– 10%.(8,9) Apathy is one of the common behavioral and psychological symptoms of dementia (BPSD) in MCI and AD.”
BackgroundNguyen, P. A. H., Kim, K., Kim, A., Kang, S., Osabutey, A. F., Jin, H., Guo, Y.-R., Park, H.-W., Suh, J., & Koh, Y. H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114520 · Cited by 15
Sadiq, M. U., Kwak, K., Dayan, E., & Initiative, A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00941-1 · Cited by 15
“Notably, this work focuses on heterogeneity of cognitive decline along the AD continuum unlike previous studies where MCI progression was examined [22, 23].”
ResultAbraham, R. P., Denton, D. A., Al-Assaf, A. S., Rutjes, A. W., Chong, L. Y., Malik, M., & Tabet, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011905 · Cited by 16
Exercise interventions for maintaining cognitive function in cognitively healthy people in late life
Forbes, S. C., Forbes, D. A., Forbes, S. C., Blake, C. M., Chong, L. Y., Thiessen, E., Rutjes, A. W., & Little, J. P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011704 · Cited by 16
Zhang, Y., Li, C., Chen, D., Tian, R., Yan, X., Zhou, Y., Song, Y., Yang, Y., Wang, X., Zhou, B., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220539 · Cited by 15
Efficacy of Akatinol Memantine in Moderate Cognitive Impairments
Levin, O. S., Iunishchenko, N. A., & Dudarova, M. A. (2010) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-010-9347-8 · Cited by 15
Hessler, J. B., Tucha, O. M., Förstl, H., Mösch, E., & Bickel, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106284 · Cited by 14
“prior to a clinical diagnosis of dementia [10] and higher rates of progression to dementia have been associated with a diagnosis of MCI [4,11–13].”
Llena, I. R., Jarca, C. I., Mundet, X., Tovar, J. L., Orfila, F., Nafría, C., Raga, A., Girona, A. S., Fernández-Lara, P., Castañé, X., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.015 · Cited by 15
“6% in community based studies [3].”
Tisato, V., Rimondi, E., Brombo, G., Volpato, S., Zurlo, A., Zauli, G., Secchiero, P., & Zuliani, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000446275 · Cited by 15
Mattos, M. K., Burke, L. E., Baernholdt, M., Hu, L., Nilsen, M. L., & Lingler, J. H. (2017) · Dementia · doi:10.1177/1471301217694250 · Cited by 15
“While older adults with MCI are at greater risk than those without MCI for developing dementia, it is not clear that everyone who develops dementia passes through a well demarcated clinical syndrome of MCI (Mitchell & Shiri-Feshki, 2008, 2009).”
Activity-Based Goals Generated by Older Adults With Mild Cognitive Impairment
Rodakowski, J. L., Becker, A. M., & Golias, K. W. (2018) · OTJR Occupational Therapy Journal of Research · doi:10.1177/1539449217751357 · Cited by 15
“Unfortunately, older adults with MCI are at risk for declining to disability (Mitchell & Shiri-Feshki, 2009), but they do not currently receive traditional rehabilitation interventions.”
BackgroundRodakowski, J. L., Golias, K. W., Reynolds, C. F., Butters, M. A., López, O. L., Dew, M. A., & Skidmore, E. R. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100368 · Cited by 15
“While this is similar to other prevention intervention protocols [36], an ideal protocol would follow participants longer, because (1) preclinical disability, while present, is subtle [33] and (2) the rate of conversion from MCI to dementia is around 10% per year [37].”
MethodCaring for Older Adults with Mild Cognitive Impairment: An Update for Nurses
Lin, F. V., Vance, D. E., Gleason, C. E., & Heidrich, S. M. (2012) · Journal of Gerontological Nursing · doi:10.3928/00989134-20121106-03 · Cited by 15
Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment?
Intzandt, B., Black, S. E., Lanctôt, K. L., Herrmann, N., OH, P. I., & Middleton, L. E. (2015) · Canadian Geriatrics Journal · doi:10.5770/cgj.18.166 · Cited by 16
“People with MCI are at high risk for dementia and may be an appropriate target for interventions for dementia prevention, such as exercise.(4-6,20,21) However, symptoms of MCI such memory problems, anxiety, and apathy may make community exercise more difficult.”
BackgroundKlekociuk, S. Z., & Summers, M. J. (2013) · European Journal of Neurology · doi:10.1111/ene.12333 · Cited by 15
“Despite evidence of higher rates of conversion from MCI to dementia [2], recent research indicates that MCI is longitudinally unstable [3,4].”
BackgroundVoices from the field: Expert reflections on mild cognitive impairment
Peters, K. R., & Katz, S. (2015) · Dementia · doi:10.1177/1471301214562135 · Cited by 16
“The rate of conversion to dementia is generally higher in clinic-based samples than in population-based samples (Farias, Mungas, Reed, Harvey, & DeCarli, 2009; Mitchell & Shiri-Feshki, 2009), which is another problem.”
BackgroundAfifi, I., Elgendy, M. A., Abdelfatah, M., & El–Sappagh, S. (2025) · Brain Informatics · doi:10.1186/s40708-025-00286-7 · Cited by 17
Thoma, M. V., Forstmeier, S., Schmid, R., Kellner, O., Xepapadakos, F., Schreiter-Gasser, U., Blessing, A., Ropohl, A., Bieri-Brüning, G., Debeer, D., et al. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0865-5 · Cited by 14
Xiao, W., Chen, Y., Li, W., Ni, Z., Liu, Y., Xu, L., Qu, J., Ng, C., & Xiang, Y. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239441 · Cited by 16
“V-CIND is associated with an increased risk of dementia, and the rate of dementia conversion in individuals with V-CIND is almost 10-fold higher than that in healthy participants (Mitchell and Shiri-Feshki, 2009).”
BackgroundGuzik-Makaruk, E. M., Pływaczewski, E. W., Laskowska, K., Filipkowski, W., Jurgielewicz-Delegacz, E., & Mroczko, P. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190259 · Cited by 14
“Ithasbeen assessed that progression to AD dementia may affect up to 35% of MCI patients, with an annual conversion rate of 5%–10% within a 3-year follow-up [12].”
Brydges, C. R., Liu-Ambrose, T. Y. L., & Bielak, A. A. M. (2020) · Neuropsychology · doi:10.1037/neu0000638 · Cited by 15
“These individuals are still capable of living independently, but are at an increased risk of developing dementia (Mitchell & Shiri-Freshki, 2009).”
BackgroundUpdate on Major Neurocognitive Disorders
Jones, K. C. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20210004 · Cited by 17
Impact of Educational Level on Versions (Basic and Complete) of the Montreal Cognitive Assessment
Díaz, L. A., Arango, A., Parra, C., Rodríguez‐Lorenzana, A., & Ponce, T. Y. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000518747 · Cited by 15
Whitfield, T. J., McConnell, B., Renouf, P., Mansour, H., Zabihi, S., Aguirre, E., Walker, Z., Cooper, C., & Marchant, N. L. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101505 · Cited by 14
“SCD or MCI), groups at increased risk of dementia (Mitchell et al., 2014; Mitchell and Shiri-Feshki, 2009).”
A Comparison of Operational Definitions for Mild Cognitive Impairment
Polcher, A. A., Wolfsgruber, S., Peters, O., Frölich, L., Wiltfang, J., Kornhuber, J., Hüll, M., Rüther, E., Lewczuk, P., Maier, W., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215548 · Cited by 17
Grässler, B., Dordevic, M., Darius, S., Herold, F., Forte, G., Langhans, C., Halfpaap, N., Müller, P., Glanz, W., Dantas, E. H. M., et al. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0042-1758862 · Cited by 15
“Based on the evidence (i) that older individuals with MCI have a higher risk of developing dementia compared with older adults with normal cognition 13 and (ii) that autonomic dysfunction is a vascular risk factor accelerating cognitive decline, 9 the evaluation of cardiac autonomic control through…”
BackgroundKang, W. (2023) · Current Psychology · doi:10.1007/s12144-023-04887-5 · Cited by 16
“Mild cognitive impairment is generally considered as a precursor to different types of dementias (Mitchell & Shiri-Feshki, 2009), which causes the loss of independence, disability, and ultimately mortality (Cotter, 2007; Gill et al., 1995; Phelan et al., 2012).”
Deep learning for risk-based stratification of cognitively impaired individuals
Romano, M. F., Zhou, X., Balachandra, A. R., Jadick, M. F., Qiu, S., Nijhawan, D. A., Joshi, P. S., Mohammad, S., Lee, P. H., Smith, M. J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107522 · Cited by 13
“Not all individuals with mild cognitive impairment (MCI) develop AD.4 To this end, several frameworks have been constructed to identify individuals with normal cognition orMCI who progress to AD.”
BackgroundInfluentialMartin, J., Reid, N., Ward, D. D., King, S. J., Hubbard, R. E., & Gordon, E. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230700 · Cited by 15
Forbes, S. C., Forbes, D. A., Forbes, S. C., Blake, C. M., Chong, L. Y., Thiessen, E., Little, J. P., & Rutjes, A. W. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011706 · Cited by 15
RetractedMasumori, N. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s28160 · Cited by 14
“Although there was no control arm in this study, it is speculated that this annual conversion rate in OAB patients receiving imidafenacin treatment is comparable with that in the general population, ie, 5%–10%, reported in a meta-analysis.(54) Of these 65 patients, 12 were followed for 48 weeks.”
Classification of Mild Cognitive Impairment Stages Using Machine Learning Methods
Cabrera-León, Y., Báez, P. G., Ruiz‐Alzola, J., & Suárez-Araujo, C. P. (2018) · IEEE International Conference on Intelligent Engineering Systems (INES) · doi:10.1109/ines.2018.8523858 · Cited by 14
“Patients with MCI have a probability of annually converting to dementia of 5−10% [5], higher than CN.”
BackgroundFamous faces naming test predicts conversion from mild cognitive impairment to Alzheimer’s disease
García, S., Cuetos, F., Novelli, A., & Martínez, C. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01483-3 · Cited by 14
Cognitive subtypes in individuals with essential tremor seeking deep brain stimulation
Ratajska, A. M., Lopez, F. V., Kenney, L. E., Jacobson, C. E., Foote, K. D., Okun, M. S., & Bowers, D. (2021) · The Clinical Neuropsychologist · doi:10.1080/13854046.2021.1882578 · Cited by 14
“Indeed, annual conversion rates of MCI to dementia in ET have ranged from 8.4% to 12.5% across studies (Radler et al., 2020; Sinoff & Badarny, 2014), compared to approximately 2% to 7% in the general population (Mitchell & Shiri-Feshki, 2009).”
BackgroundInfluentialKwon, L.-N., Yang, D., Hwang, M., Lim, S., Kim, Y., Kim, J.-G., Cho, K.-H., Chun, H.-W., & Park, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182413235 · Cited by 15
Saunders, S., Ritchie, C. W., Russ, T. C., Terrera, G. M., & Milne, R. (2022) · BMC Geriatrics · doi:10.1186/s12877-021-02693-x · Cited by 16
Automated MR morphometry to predict Alzheimer’s disease in mild cognitive impairment
Fritzsche, K. H., Stieltjes, B., Schlindwein, S., van Bruggen, T., Essig, M., & Meinzer, H.-P. (2010) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-010-0412-0 · Cited by 14
Boespflug, E. L., Storrs, J. M., Sadat-Hossieny, S., Eliassen, J. C., Shidler, M. D., Norris, M. M., & Krikorian, R. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0506-x · Cited by 14
“While clinical classification of individuals with MCI provides a means for identifying those at an increased risk for progression, not all persons with MCI progress to AD (Mitchell and Shiri-Feshki 2009).”
BackgroundPakdaman, H., Harandi, A. A., Abbasi, M., Kasmaei, H. D., Ashrafi, F., Gharagozli, K., Assarzadegan, F., Behnam, B., & Ahmadi, M. A. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000458521 · Cited by 14
Schönknecht, O. D. P., Hunt, A. M., Toro, P., Henze, M., Haberkorn, U., & Schröder, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.014 · Cited by 13
Therapeutic Use and Chronic Abuse of CNS Stimulants and Anabolic Drugs
Coliță, D., Coliță, C.-I., Hermann, D. M., Coliță, E., Doeppner, T. R., Udriștoiu, I., & Popa‐Wagner, A. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100333 · Cited by 13
“Moreover, between 10 and 20% of individuals above the age of 65 are diagnosed with mild cognitive impairment (MCI) [4], and of these, 10% will progress to AD [5].”
BackgroundBandini, J. I., Schulson, L., Ahluwalia, S. C., Harrison, J. M., Chen, E. K., Lai, J., & Edelen, M. O. (2022) · Gerontology and Geriatric Medicine · doi:10.1177/23337214221131403 · Cited by 16
“CI is characterized by a decline in cognition greater than expected for an individual’s age and education level but without significant interference in everyday activities (Mitchell & Shiri-Feshki, 2009; Panegyres et al., 2016).”
BackgroundManser, P., Michels, L., Schmidt, A., Barinka, F., & de Bruin, E. D. (2023) · JMIR Research Protocols · doi:10.2196/41173 · Cited by 14
“The annual conversion rate of mNCD to MNCD is approximately 4.9 in community settings and 9.6 in specialist clinical settings [31].”
InfluentialTorrealba, E., Aguilar-Zerpa, N., Garcia-Morales, P., & Díaz, M. L. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220116 · Cited by 15
“In addition, a recent meta-analysis have concluded that the rate of conversion of MCI to dementia is approximately 5% to 10% over a period of 10 years [4].”
BackgroundSale, A., Noale, M., Cintoli, S., Tognoni, G., Braschi, C., Berardi, N., Maggi, S., Maffei, L., Maffei, L., Picano, E., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afad067 · Cited by 14
Zhao, Q. X., Du, X., Chen, W., Zhang, T., & Xu, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1216215 · Cited by 17
Kasprzak, D., Kaczmarek‐Majer, K., Rzeźniczak, J., Klamecka-Pohl, K., Ganowicz-Kaatz, T., Słomczyński, M., Budzianowski, J., Pieszko, K., Hiczkiewicz, J., Tykarski, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154954 · Cited by 15
“However, it is associated with an increased risk of developing dementia, with an annual progression rate of between 5 and 10% [3].”
BackgroundBevilacqua, R., Felici, E., Cucchieri, G., Amabili, G., Margaritini, A., Franceschetti, C., Barboni, I., Paolini, S., Civerchia, P., Raccichini, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196129 · Cited by 13
“, while in the evening it was asked ‘How much MCI are often not included in the research in the technological field while public and patient involvement, especially in an interdisciplinary design and health-care context, is important to bring together, adapt and develop acceptable and usable technologies.”
BackgroundInfluentialSenczyszyn, A., Szcześniak, D., Wieczorek, T., Maciaszek, J., Malecka, M., Bogudzińska, B., Zimny, A., Fila-Pawłowska, K., & Rymaszewska, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1196478 · Cited by 15
A qualitative study of informal caregiver perceptions of the benefits of an early dementia diagnosis
Couch, E., Co, M., Albertyn, C. P., Prina, M. A., & Lawrence, V. C. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10957-6 · Cited by 13
“MCI is a significant predictor of future dementia, with approximately 7% of people with MCI developing dementia annually [7, 8].”
BackgroundTsiakiri, A., Bakirtzis, C., Plakias, S., Vlotinou, P., Vadikolias, Κ., Terzoudi, A., & Christidi, F. (2024) · Biomedicines · doi:10.3390/biomedicines12061232 · Cited by 13
“Progression from minor to major NCD varies widely, typically occurring within 3 to 5 years, and is influenced by factors such as age, genetics, and comorbid conditions [13].”
BackgroundCheng, S., Shang, P., Zhang, Y., Guan, J., Chen, Y., Lv, Z., Huang, S., Liu, Y., & Xie, H. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106646 · Cited by 13
Metadata
- Authors
- Mitchell, A. J., & Shiri‐Feshki, M.
- Affiliations
- University of Leicester (GB)
- Nottinghamshire Healthcare NHS Foundation Trust (GB)
- Corresponding author
- Mitchell, A. J.
- ORCID
- Mitchell, A. J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2009-03-03
- Volume
- 119
- Issue
- 4
- Pages
- 252-265
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2052226124
- Cited by
- 1,659
- References
- 87
- Citations by year
- 2026: 84 · 2025: 98 · 2024: 135 · 2023: 118 · 2022: 129 · 2021: 176 · 2020: 165 · 2019: 115 · 2018: 96 · 2017: 86 · 2016: 88 · 2015: 85 · 2014: 62 · 2013: 75 · 2012: 55
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Acta Psychiatrica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- mild cognitive impairment, dementia progression, Alzheimer's disease, vascular dementia, Mayo criteria
- MeSH terms
- Aged, Alzheimer Disease, Cognition Disorders, Dementia, Follow-Up Studies, Humans, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Dementia, Vascular, Cohort Studies, Prevalence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review